CYTOR and breast carcinoma: Wu et al. (51) found that LINC00152 knockdown inhibits breast cancer cell invasion, migration, tumor growth, and colony growth, and triggers apoptosis through a mechanism that activates breast cancer type 1 (BRCA1)/phosphatase and tensin homolog (PTEN) via DNA methyltransferase (DNMT) inactivation (51).